010600 — WellBiotec Co Cashflow Statement
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
Annual cashflow statement for WellBiotec Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS/A | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16,553 | -67,825 | -33,298 | -21,024 | -66,372 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 9,097 | 63,806 | 13,286 | 24,143 | 58,564 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,017 | -4,563 | -2,026 | -2,500 | 2,167 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7,727 | -5,705 | -19,753 | 1,980 | -4,168 |
Capital Expenditures | -6,100 | -1,276 | -763 | -509 | -1,083 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,196 | -25,683 | 8,882 | 17,040 | -21,548 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8,296 | -26,959 | 8,120 | 16,531 | -22,630 |
Financing Cash Flow Items | -63.8 | 86.2 | -79.7 | -30.1 | -55.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8,138 | 23,781 | 13,701 | -11,788 | 26,480 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7,837 | -8,910 | 2,161 | 6,504 | -329 |